Role of nitric oxide (NO) in pregnancy and in preeclampsia;Role du monoxyde d'azote (NO) dans la grossesse et dans la preeclampsie

Nephrologie

Volumn 18, Issue 3, 1997, Pages 81-90

  Boulanger, H ^a   Berkane, N ^a   Pruna, A ^b  

^a HÔPITAL TENON   (France)

^b FOCH HOSPITAL   (France)

Author keywords

Endotheline; Nitric oxide; Preeclampsia; Pregnancy; Prostaglandins

Indexed keywords

ACETYLCHOLINE; ANTITHROMBOCYTIC AGENT; ARACHIDONIC ACID; ARGININE; BRADYKININ; CALCIUM; CD23 ANTIGEN; CYCLIC GMP; CYCLIC GMP DEPENDENT PROTEIN KINASE; ENDOTHELIN; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; ENDOTHELIUM DERIVED HYPERPOLARIZING FACTOR; ENDOTHELIUM DERIVED RELAXING FACTOR; ESTROGEN; FLAVINE ADENINE NUCLEOTIDE; GUANOSINE TRIPHOSPHATE; INDOMETACIN; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; PHOSPHOLAMBAN; PROSTACYCLIN; PROSTAGLANDIN; SEROTONIN; THROMBOPLASTIN; THROMBOXANE A2; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; NITROPRUSSIDE SODIUM;

BLOOD PRESSURE; FEMALE; FETOPLACENTAL UNIT; HEMODYNAMICS; HUMAN; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; NONHUMAN; PLACENTA CIRCULATION; PREECLAMPSIA; PREGNANCY; PROSTAGLANDIN METABOLISM; REVIEW; UTERUS; VASODILATATION; ANIMAL; KIDNEY CIRCULATION; NATRIURESIS; PATHOPHYSIOLOGY; PHYSIOLOGY; PLACENTA; PREGNANCY COMPLICATION; RAT; THROMBOSIS; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ARGININE; BLOOD PRESSURE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; NATRIURESIS; NITRIC OXIDE; NITROPRUSSIDE; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; RATS; RENAL CIRCULATION; THROMBOSIS; VASODILATION;

EID: 0030748231     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (117)

1. Lindheimer MD, Katz AI. The kidney and hypertension in pregnancy, In Brenner BM, Rector FC. eds. The Kidney. Philadelphia : Saunders Co, 1991 ; 1551-95.
2. Moncada S, Gryglewski R, Bunting S, Vane JR. An enzyme isolated from arteries transforms prostaglandin endoperoxidase to an unstable substance that inhibits platelet aggregation. Nature 1976 ; 263 : 663-5.
3. Whalen JB, Constance MD, Van Orden DE. Plasma prostaglandins in pregnancy. Obstet Gynecol 1978 ; 51 : 52-5.
4. Paller SM, Ferris TF. The Kidney and hypertension in pregnancy. In The kidney, Brenner BM, Rector FC, Eds. Philadelphia: Saunders Co, 1995; 1731-63.
5. Weiner CP. et al. Effect of pregnancy on endothelium and smooth muscle cells ; their role in reduced adrenergic sensitivity. Am J Physiol 1991 ; 261 : H1275-H83.
6. Walsh SW. Pre-eclampsia : An imbalance in placental prostacyclin and thromboxane synthesis. Am J Obstet Gynecol 1985 ; 152 : 335-40.
7. Benigni A, Gregorini G, Frusca T, et al. Effect of low dose aspirine on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancy-induced hypertension. N Engl J Med 1989 ; 321 : 357-62.
8. Thorp JA, Walsh SW, Brath PC. Low-dose aspirin inhibits thromboxane, but not prostacyclin production by human placental arteries. Am J Obstet Gynecol 1988 ; 159 : 1381-4.
9. Beaufils M, Uzan S, Donsimoni R, Colau J-C. Prevention of preeclampsia by early antiplatelet therapy. Lancet 1985 ; 1 : 840-2.
10. Hauth JC, Goldenberg RL, Parker CR, et al. Low-dose aspirin therapy to prevent preeclampsia. Am J Obstet Gynecol 1993 ; 168 : 1083-93.
11. Imperiale TF, Petrulis AS. A meta analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991 ; 266 : 260-4.
12. Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, Paul RH, Romero R, Witter F, Rosen M, Depp R, and the National Institute of Child Health and Human Developement Network of Maternal-Fetal Medecine Units. Prevention of pre-eclampsia with low-dose aspirin in healthy nulliparous pregnant women. N Engl J Med 1993 ; 329 : 1213-8.
13. CLASP. A randomised trial of low-dose aspirin for the prevention and treatement of preeclampsia among 9364 pregnant women. Lancet 1994 ; 343 : 619-29.
14. Italian study of aspirin in pregnancy. Low-dose aspirin in prevention and treatement of intrauterine growth retardation and pregnancy-induced hypertension. Lancet 1993 ; 341 : 396-400.
15. ECPPA. Randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women. Br J Obst Gynecol 1996 ; 103 : 39-47.
16. Kirk P, Conrad M, Colpoys MC. Evidence against the hypothesis that prostagandins are the vasodepressor agents of pregnancy. J Clin Invest 1986 ; 77 : 236-45.
17. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetycholine. Nature 1980 ; 299 : 373-6.
18. Palmer RMJ, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987 ; 327 : 524-6.
19. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988 ; 332 : 411-5.
20. Florijn KW, Derkx FHM, Visser W, Hofman JA, Rosmalen FMA, Wallenburg HCS, Schalekamp MADH. Plasma immunoreactive Endothelin-1 in pregnant women with and without preeclampsia. J Cardiovasc Pharmacol 1991 ; 17 (Suppl.7) : S446-S8.
21. Friedman SA, Lubarsky SL, Ahokas RA, Nova A, Sibai BM. Preeclampsia and related disorders : Clinical aspects and relevance of endotheline and nitric oxyde. Clin Perinat 1995 ; 22 : 343-5.
22. Chwalisz K, Kaufmann P, Garfield RE. Nitric oxide (NO) deficiency as the mechanism of the preeclampsia. Premières journées annuelles Genesis, 16-17 septembre 1995.
23. Conrad KP. Vasoactive mediators in normal pregnancy and preeclampsia. Madrid, Spain. ISN July, 1995 (Abstr).
24. Conrad KP, Joffe GM, Kruszyna H, Kruszyna R, Rochelle LG, Smith RP, Chavez JF, Mosher MD. Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993 ; 7 : 566-71.
25. Conrad KP, Vernier KA. Plasma level, urinary excretion and metabolic production of cGMP during gestation in rats. Am J Physiol 1989 ; 257 : R847-R53.
26. Diket AL, Pierce MR, Munshi UK, Voelker CA, Eloby-Childress S, Greenberg SS, Zhang X, Clark DA, Miller MJS. Nitric oxide inhibition causes intra-uterine growth retardation and hind limbs disruption in rats. Am J Obstet Gynecol 1994 ; 171 : 1243-50.
27. w-nitro-L-Arginine, an inhibitor of nitric oxide synthesis, increases blood pressure in rats and reverses the pregnancy-induced refractoriness to vasopressor agents. Am J Obstet Gynecol 1992 ; 166 : 1560-7.
28. Molnar M, Suto T, Toth T, Hertelendy F. Prolonged blocage of nitric oxyde synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia and intra-uterine growth retardation. Am J Obstet Gynecol 1994 ; 170 : 1458-66.
29. Nathan L, Cuevas J, Chaudhuri G. The role of nitric oxide in the altered vascular reactivity of pregnancy in the rat. Br J Pharmacol 1995 ; 114 : 955-60.
30. Yallampalli G, Garfield RE. Inhibition of nitric oxyde synthesis during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993 ; 169 : 1316-20.
31. Snyder SH. Endothelial NO. Nature 1995 ; 337 : 196-7.
32. De Beider A, Lees C, Martin J, Moncada S, Campbell S. Treatement of HELLP syndrome with nitric oxide donor. Lancet 1994 ; 345 : 124-5.
33. Feletou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988 ; 93 : 515-24.
34. Rubanyi GM, Vanhoutte PM. Nature of endothelium-derived relaxing factor : Are there two relaxing mediators ? Circ Res 1987 ; (Suppl. II) : 61-7.
35. Taylor SG, Weston AH. Endothelium-derived hyperpolarizing factor. A new endogenous inhibitor from the vascular endothelium. Trends Pharmacol Sci 1988 ; 9 : 272-4.
36. Vanhoutte PM, Auch-Schwelk W, Boulanger C, Janssen PA, Katusic ZS, Komori K, Miller VM, Shini VB, Vidal M. Does Endothelin-1 mediate endothelium dependent contraction during anoxia? J Cardiovasc Pharmacol 1989 ; 13 : S124-S8.
37. Vanhoutte PM, Katusic ZS. Endothelium-derived contracting factor : Endothelin and/or Superoxide anions ? Trends Pharmacol Sci 1988 ; 9 : 229-30.
38. Luscher TF, Boulanger C, Dohi Y, Yang Z. Endothelium-derived contracting factors. Hyprtension 1992 ; 19 : 117-30.
39. Rubanyi GM. Endothelium derived relaxing and contractility factors. J Cell Biochem 1991 ; 46 : 27-36.
40. Vanhoutte PM, Eber B. Endothelium-derived relaxing and contracting factors. Wien Klin Wochenschr 1991 ; 103 : 405-11.
41. Waddington S, Cook HT, Reaveley D, Jansen A, Cattel V L-Arginine dëplétion inhibits glomerular nitric oxide synthesis and exacerbates rat nephrotoxic nephritis. Kidney Int 1996 ; 49 : 1090-6.
42. Moncada S, Palmer RMJ, Higgs EA. Biosynthesis and endogenous roles of nitric oxide. Pharmacol Rev 1991 ; 43 : 109-42.
43. Weiner CP, Lizasoain I, Baylis S, Knowles RG, Charles I, Moncada S. Induction of calcium-dependent nitric oxide synthases by sex hormones. Proc Natl Acad Sci USA 1994 ; 91 : 5212-6.
44. Mc Quillan LP, Leug GK, Marsden PA, Kostylk SK, Kourembanas S. Hypoxia inhibits expression of eNOS via transcriptional and postranscriptional mechanisms. Am J Physiol (Heart) 1994 ; 267 : H1921-H7.
45. Michel JB, Arnal JF. Monoxyde d'azote et hypertension artérielle. Médecine/Sciences. Paris: Flammarion, 1993 ; 9 : 1061-7.
46. Yang Z, Von Segesser L, Bauer E, Stulz P, Turina M. et al. Different interactions of platelets with arterial and venous coronary bypass vessels. Lancet 1991 ; 337 : 939-43.
47. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994 ; 298 : 249-58.
48. Thiemermann C. Inhibition des NO synthases dans la défaillance circulatoire : effet bénéfique ou délétère ? Médecine/sciences. Paris: Flammarion, 1995 ; 11 : 1643-51.
49. Paul-Eugène/Dugas N, et al. Rôle du CD23 dans la production de monoxyde d'azote par les monocytes humains. Médecine/sciences. Paris: Flammarion. 1995 ; 11 : 1653-9.
50. Nathan C, Xie Q. Nitric oxide synthases : Roles, tolls, and controls. Cell 1994 ; 78 : 915-8.
51. Yang W, Marsden AP Nitric oxide synthases : Biochemical and molecular regulation. Curr Opin Nephrol Hypert 1995 ; 4 : 12-22.
52. Weiner CP, Martinez E, Liu ZK, Ghodshi A, Chestnut DH. In vitro release of endothelium derived relaxing factors by acetylcholine is increased during the guinea pig pregnancy. Am J Obstet Gynecol 1989 ; 161 : 1599-605.
53. Fievet P, Gregoire I, Fournier A, Roth D, Siegenthaler G, El Esper N, Favre H, De Bold A. Ouabain-like natriuretic factor and atrial factor in pregnancy. Kidney Int 1988 ; 34 (Suppl.) : 89-92.
54. Weiner CP, Knowles RG, Moncada S. Induction of nitric oxide synthase early in pregnancy. Am J Obst Gynecol 1994 ; 171 : 838-43.
55. Ahokas RA, Sibai BM. Endothelium - derived relaxing factor inhibition augments vascular angiotensine II reactivity in the pregnant rat hind limb. Am J Obstet Gynecol 1992 ; 167 : 1053-8.
56. Weiner CP, Martinez E, Chestnut DH, Ghodsi A. Effect of pregnancy on uterine and carotid artery response to norepinephrine, epinéphrine and phenylephrine in vessel with documented fonctionnal endothelium. Am J Obstet Gynecol 1989 ; 161 : 1605-10.
57. Paller MS, Gregorini G, Ferris TF. Pressor responsiveness in pseudopregnant and pregnant rats : Role of maternal factor Am J Physiol 1999 ; 257 : R866-R71.
58. Miller VM, Vanhoutte PM. Progesterone and modulation of endothelium-dependent responses in canine coronary arteries. Am J Physiol 1991 ; 261 : R1022-R7.
59. Horowitz KB, Horowitz ID. Canine vascular tissuees are targets for androgens, estrogens, progestins and glucocorticoids. J Clin Invest 1982 ; 69 : 750-9.
60. Lin AL, Shain SA. Estrogen mediated cytoplasmic and nuclear distribution of rat cardiovascular estrogen receptors. Arteriosclerosis 1985 ; 5 : 668-77.
61. Orimo A, Inoue S, Ikegami A, Hosoi T, Akishita M, Ouchi Y, Muramatsu M, Orimo H. Vascular smooth muscle cells are target for estogen. Biochem Biophys Res Commun 1993 ; 195 : 730-6.
62. Bayard F, Clamens S, Meggetto F, Blaes N, Delsol G, Faye JC. Estrogen syntheis, estrogen metabolism, and functional estrogen receptors in rat arterial smooth muscle cells in culture. Endocrinology 1995 ; 136 : 1523-9.
63. Perrot-Aplanat M, Groyer- Picard MT, Lorrenzo F, Milgrom E. Immunocytochemical demonstration of estrogen and progesterone receptors in muscle cells of uterine arteries in rabbits and humans. Endocrinology 1988 ; 123 : 1511-9.
64. Lantla M, Karkkainen J, Lehtovirta P. Progesterone and estradiol receptors in the cytosol of the human uterine artery. Am J Obstet Gynecol 1983 ; 147 : 627-33.
65. Lieberman JR, Van Vroonhoven CCJ, Beckman I. Van de Kast TH, Wallemburg HCS. Uterine artery estrogen receptors in the non pregnant and pregnant guinea pig. Am J Obstet Gynecol 1990 ; 163 : 1685-8.
66. Stallone JN, Crofton JT, Share L. Sexual dysmorphism in vasopressin-induced contraction in rat aorta Am J Physiol 1991 ; 260 : H453 -8.
67. Shan J, Resnick LM, Liu QY, Wu XC, Barbagallo M, Pang PK. Vascular effects of 17-beta estradiol in male Sprague-Dawley rats. Am J Physiol 1994 ; 266 : H967-H73.
68. 2 in porcine coronary artery. Circulation 1995 ; 91 : 2619-26.
69. Farhat MY, Lavigne M, Amwell W. The vascular protective effects of estrogen. FASEB J 1996 ; 10 : 615-24.
70. Van Buren GA, Yang D, Clark KE, Estrogen- induced uterine vasodilatation is antagonized by L-Nitroarginine methyl ester, an inhibitor of nitric oxide synthesis. Am J Obstet Gynecol 1992 ; 167 : 828-33.
71. Chang WC, Nakao J, Orimo H, Murota SI. Stimulation of prostacyclin cyclooxygenase and prostacyclin synthetase activities by estradiol in rat aortic smooth muscle cells. Biochem Biophys Acta 1980 ; 620 : 472- 82.
72. Morris NH, Sooronna SR, Eaton BM, Steer PJ. NO synthase activity in placental bed and tissues from normotensive pregnant women. Lancet 1993 ; 342 : 679-80.
73. Myatt L, Brockman DE, Eis AL, Pollock JS. Immunohistological localization of nitric oxide in the human placental villous tree. Placenta 1993 ; 14 : 487-95.
74. Myatt L, Brockman DE, Langdon G, Pollock JS. Constitutive calcium dependant isoform of nitric oxide synthase in the human placental villous vascular tree. Placenta 1993 ; 14 : 373-83.
75. Chaudhuri G, Cuevas J, Buga GM, Ignarro LJ. NO is more important than PGI2 in maintaining low vascular tone in fet-placental vessels. Am J Physiol 1993 ; 265 : H2036-H43.
76. Myatt L, Brewes A. The action of nitric oxide in the perfused human fetal placental circulation. Am J Obstet Gynecol 1991 ; 164 : 687-92.
77. Howard RB, Hosokawa T, Maguire MH. Hypoxia induced fetoplacental vasoconstriction in perfused human placental cotyledons. Am J Obstet Gynecol 1987 ; 157 : 1261-6.
78. Ito S. Nitric oxide in the kidney. Curr Opin Nephrol Hypert 1995 ; 4 : 23-30.
79. Raij L, Baylis C. Glomerular actions of nitric oxide. Kidney Int 1995 ; 48 : 20-32 (Editorial Review).
80. Chen PY, Sanders PW. L-Arginine abrogates salt-sensitive hypertension in Dahl-Rapp rats. J Clin Invest 1991 ; 88 : 1559-67.
81. De Nicola L, Blantz RC, Gabbai FB. Nitric oxide and angiotensine II glomerular and tubular interaction in the rat. J Clin Invest 1992 ; 89 : 1248-56.
82. Ito S, Arima S, Ren YL, Juncos LA, Carretero OA. Endothelium - derived relaxing factor/nitric oxide modulates angiotensin II action in the isolated microperfused rabbit afferent but not efferent arteriole. J Clin Invest 1993 ; 91 : 2012-9.
83. Davidson JM, Dunlop W. Renal hemodynamics and tubular functions in normal human pregnancy. Kidney Int 1980 ; 18 : 152.
84. Danielson LA, Conrad KP Acute blockade of nitric oxide synthase inhibits renal vasodilatation and hyperfiltration during pregnancy in chronically instrumented conscious rats. J Clin Invest 1995 ; 96 : 482-90.
85. Conrad KP, Vill M, Mc Guire PG, Dail WG, Davis AK. Expression of nitric oxide synthase by scyncytiotrophoblast in human placental villi. FASEB J 1993 ; 7 :1269-76.
86. Roberts JM, Taylor RN, Goldfien A. Clinical and biochemical evidence of endothelial cell dysfunction in the pregnancy syndrome preeclampsia. Am J Hypert 1991 ; 4 : 700-8.
87. Abitbol MM, Ober WB, Gallo GR, et al. Experimental toxemia of pregnancy in the monkey with a preliminary report on renin and aldosterone. Am J Pathol 1977 ; 86 : 573-83.
88. Combs CA, Katz MA, Kitz-Miller JL, et al. Experimental preeclampsia produced by chronic constriction of the aorta in conscious Rhesus monkey. Am J Obstet Gynecol 1993 ; 169 : 215-23.
89. Rodgers GM. Hemostatic properties of normal and pertubed vascular cells. FASEB J 1988 ; 2 : 116-23.
90. Spargo BH, Mc Cartney CP, Weinmiller R. Glomerular endotheliosis in toxemia of pregnancy. Arch Pathol 1959 ; 68: 593-9.
91. Friedman SA, Taylor RN, Roberts JM. Pathophysiology of preeclampsia. Clin Perinat 1991 ; 18 : 661-82.
92. Starkey PM. The decidua and factors controlling placentation. In The human placenta, Redmann CWG, Sargent IL, Starkey PM, Eds. Oxford : Blackwell, 1993 ; 362-413.
93. Ward K, Hata A, Jeunemaitre X. et al. A molecular variant of angiotensinogen associated with preeclampsia. Nature 1993 ; 4: 59-61.
94. Milliez J, Edelman P. La prééclampsie : maladie immunitaire ? In Immunologie de la reproduction. Voisin GA, Edelman P, Genetet N, Bach JF, Sureau C, eds. Médecine/Sciences Paris : Flammarion, 1990 : 257-65.
95. Chaouat G, Szekeres-Bartho J, Menu E, Kinsky R, Thang MN, Dy M, Minkowski M, Clark D, Wegmann T. Immunologie de la relation materno-fœtale. Paris: Flammarion. 1989 ; (No spécial) 20-6.
96. Redman CWG, Bodmer JG, Bodmer WF, Beilin LJ, Bonnar J. HLA antigens in severe preeclampsia. Lancet 1978 ; 2 : 397-9.
97. Redman CWG. Immunology of preeclampsia. Seminars Perinat 1991 ; 15 : 257-62.
98. Robillard PY, Hulsey TC, Papiernik E. Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet 1994 ; 344 : 973-5.
99. Feeney JG, Tovey LAD, Scott JS. Influence of previous blood transfusions on incidence of preeclampsia. Lancet 1977 ; 1 : 874-5.
100. Everett RB, Worley RJ, Mac Donald PG, Gant NF. Effect of prostaglandin synthetase inhibitors on pressor response to angiotensin II in human pregnancy. J Clin Endoc Metabol 1978 ; 46 : 1007-10.
101. Mc Carthy AL, Woolsfon RG, Raju SK, et al. Abnormal endothelial cell function of resistance arteries from women with preeclampsia. Am J Obstet Gynecol 1993 ; 168 : 1323-30.
102. Pinto AR, Sorrentino P, Sorrentino T, et al. Endothelial-derived relaxing factor released by endothehals cells of human umbilical vessels and its impairement in pregnancy-induced hypertension. Am J Obstet Gynecol 1991 ; 164 : 507-13.
103. Pinto A, Sorrentino R, Sautebin L, Miranda L, Sorrentino P. Identification and partial purification of an endothelial-derived relaxing factor-inhibitor factor(s) in serum of hypertensive preeclamptic parturients. In : Biology of Nitric Oxide. London : Portland Press. 1992 ; 373-6.
104. Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GSJ. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993 ; 342 : 242-3.
105. Seligman SP, Buyon JP, Clancy RM, Young BK, Abramson SB. The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994 ; 171 : 944-8.
106. Davidge ST, Billiar TR, Roberts JM. Plasma nitrites and nitrates, stable end products of nitric oxide, are elevated in women with preeclampsia Poceedings of the 9th international Conference ISSHP ; 1994. A60-164.
107. Cameron IT, Van Papendorp CL, Palmer RMJ. Relationship between nitric oxide synthesis and increase in systolic blood pressure in women with hypertension in pregnancy. Hypertens Pregnancy 1993 ; 85-92.
108. Barton JR, Sibai BM, Ahokas RA, Whybrew D, Mercer BM. Magnesium sulfate therapy in preeclampsia is associated with increased urinary cyclic guanosine monophosphate excretion. Am J Obstet Gynecol 1992 ; 167 : 931-4.
109. Baker PN, Davidge ST Roberts JM. plasma from women with preeclampsia increases endothelial cell nitric oxide production. Hypertension 1995 ; 26 : 244-8.
110. Davidge ST, Baker PN, Roberts JM. NOS expression is increased in endothelial cells exposed to plasma from women with preeclampsia. Am J Physiol 1995 ; 269 : H1106 -H12.
111. Richer C, Boulanger H, ES Slamis, Guidicelli JF. Lack of beneficial effects of the NO-donor molsidomine, in the L-NAME niduced preeclamptic syndrome in pregnant rats. Br 5 Pharmacol 1996; 119: 1642-8.
112. Ramsay B, de Beider A, Campbell S, Moncada S. A nitric oxyde donor improves uterine artery diastolic blood flow in normal early pregnancy and in women at hight risk of preeclampsia. Eur J Clin Invest 1994 ; 24 : 76-8.
113. Boulanger H, Boulanger R, Colau JC, Pruna A. Improvement of a toxemic pregnancy with molsidomine, a nitric oxide donor. Nephrol Dial Transplant 1996 ; (letter) 11: 391.
114. Shultz PM, Raij L. Endogenously synthesized nitric oxide prevents endotoxin-induced glomerular thrombosis. J Clin Invest 1992: 90: 1718-25.
115. Raij L, Coffee K, Guerra J, Holmes D. Glomerular thrombosis in pregnancy. Role of the L-Arginine nitric oxide pathway. Kidney Int 1994 ; 45 : 775-81.
116. Westberg G, Shulta PJ, Raij L. Exogenous nitric oxide prevents endotoxin-induced glomerular thrombosis in rat. Kidney Int 1994 ; 46 : 711-6.
117. Clarkson P, Adams MR, Powe AJ, Donald AE, Mc Credie R, Robinson J, Mc Carthy SN, Keech A, Celermajer DS, Deanfield JE. Oral L-Arginine improve endothelium -dependent dilatation in hypercholesterolemic young adults. J Clin Invest 1996 ; 97 : 1989-94.